Equity · Healthcare
CHE
NYSEChemed (CHE)
The line runs 541 USD on 12 August through 538.49 USD on 9 November, on a scale from 480 to 560. Days the market did not trade hold the previous close, flat.
- Market cap
- 7.0B USD
- P/E (TTM)
- 25.8
- Revenue, year to Dec 2025
- 2.5B USD
- EPS, diluted, year to Dec 2025
- 18.34 USD
- 52-week range
- 368 USD – 552 USD
- Avg volume
- 8.7K
- Mentions, 30 days
- 23
- Net sentiment
- +0.17
as of Nov 9, 2026
Have Chemed (CHE) insiders bought or sold shares recently?
In the 90 days to 10 Nov 2026, Chemed insiders reported 6 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 21 Oct 2025, show no open-market purchase.
Form 4, 90 days to 10 Nov 2026, newest reported trade 3 Nov 2026
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 03 Nov 2026 | MCNAMARA KEVIN Jpresident and CEO | Sell | 2,000 | 1.1M USD |
| 02 Nov 2026 | LEE SPENCER Sexecutive vice president | Sell | 920 | 494K USD |
| 28 Sep 2026 | MCNAMARA KEVIN Jpresident and CEO | Sell | 2,000 | 1.0M USD |
| 18 Sep 2026 | MCNAMARA KEVIN Jpresident and CEO | Sell | 2,000 | 1.0M USD |
| 21 Aug 2026 | LEE SPENCER Sexecutive vice president | Sell | 1,000 | 541K USD |
| 21 Aug 2026 | MCNAMARA KEVIN Jpresident and CEO | Sell | 2,000 | 1.1M USD |
| Sold | 6 open-market sales | 9,920 | $5.22M |
4 other filings in the window: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 30 Sep 2026 | LEE SPENCER Sexecutive vice president | Option exercise | 12,099 | 5.4M USD |
| 30 Sep 2026 | LEE SPENCER Sexecutive vice president | Tax withheld | 11,160 | 5.7M USD |
| 28 Sep 2026 | HUTTON THOMAS Cvice president | Option exercise | 4,629 | 2.1M USD |
| 28 Sep 2026 | HUTTON THOMAS Cvice president | Tax withheld | 4,270 | 2.2M USD |
Which funds hold Chemed (CHE)?
1 of the 45 institutional funds we track reported a Chemed position for the quarter ended 30 Sep 2026 — a combined 3.8M USD; the latest of those filings landed 06 Nov 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Fisher Asset Management | Held (±25%) | 7,620 | 3.8M USD | +0.7% |
Have members of Congress traded Chemed (CHE)?
The most recent congressional trade disclosed in Chemed is a purchase by Lisa C. McClain (house, MI), dated 24 Jun 2025.
STOCK Act disclosures
| Traded | Member | Type | Amount | Filed after |
|---|---|---|---|---|
| 24 Jun 2025 | Lisa C. McClainhouse · Republican–MI | Purchase | 1K USD–15K USD | 50 days |
| 06 Mar 2025 | Byron Donaldshouse · Republican–FL | Sale | 1K USD–15K USD | 39 days |
| 31 Jan 2023 | Daniel S. Goldmanhouse · Democrat–NY | Sale | 1K USD–15K USD | 24 days |
What has been filed or recorded for Chemed (CHE)?
The filings we hold for Chemed, newest first: 2 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 14 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 14 Oct 2026 | Fails to deliver | Shares failed to deliver | 3,785 shares | 1.9M USD notional · 0.029% of shares out |
| 09 Oct 2026 | Fails to deliver | Shares failed to deliver | 7 shares | 3K USD notional · <0.001% of shares out |
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS 5.45 USD | Revenue $691M |
| 30 Sep 2026 | Financials | Total assets | 1.7B USD | at period end |
| 30 Sep 2026 | Financials | Total equity | 861.4M USD | at period end |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS 5.13 USD | Revenue $673M |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS 4.84 USD | Revenue $658M |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS 18.34 USD | Revenue $2.53B |
| 31 Dec 2025 | Financials | Revenue | 2.5B USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | 265.2M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | 18.34 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS 4.46 USD | Revenue $625M |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS 3.57 USD | Revenue $619M |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS 4.86 USD | Revenue $647M |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS 19.89 USD | Revenue $2.43B |
What is Reddit saying about Chemed (CHE)?
Reddit mentioned CHE 23 times in the 30 days to 10 November 2026, across 5 of the communities we track. All of them were scored for sentiment: 87% read bullish, 0% bearish and 13% neither. Reddit data updated 10 November 2026.
30-day window, Method
How do Reddit mentions of Chemed (CHE) compare with its price?
Share ↗
Which subreddits are talking about Chemed (CHE)?
30 days
| Community | Share | Mentions | Net sentiment |
|---|---|---|---|
| r/wallstreetbets | 48% | 11 | +0.10 |
| r/etfs | 35% | 8 | +0.24 |
| r/commodities | 9% | 2 | +0.27 |
| r/cryptocurrency | 4% | 1 | +0.31 |
| r/stocks | 4% | 1 | +0.16 |
Which names move with Chemed (CHE) on Reddit?
Csl.ax moved most closely with Chemed (CHE): when the crowd talked about one, it talked about the other (+0.69 over 31 days). Co-discussion, not price.
WEBN | ||||||
|---|---|---|---|---|---|---|
CHE | +0.69 | +0.69 | +0.67 | +0.64 | +0.61 | +0.60 |
View the matrix as a tableHide the table
| Pair | Match | Days measured |
|---|---|---|
| CHE and Csl.ax | +0.69 | 31 days |
| CHE and LRCX | +0.69 | 31 days |
| CHE and MUSE | +0.67 | 31 days |
| CHE and IBM | +0.64 | 31 days |
| CHE and SES | +0.61 | 31 days |
| CHE and WEBN | +0.60 | 31 days |
What do people ask about Chemed (CHE)?
What did Chemed shares close at?538.49
Chemed closed at 538.49 USD on 9 Nov 2026, up 1.97% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Chemed’s market cap?7.0B
Chemed is worth 7.0B USD by market value as of 9 Nov 2026, which is the share price times the shares on issue from its SEC filings.
What is Chemed’s P/E ratio?25.8
Chemed has a price-to-earnings ratio of 25.8, as of 9 Nov 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.
What is Chemed’s revenue?2.5B
Chemed reported revenue of 2.5B USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Chemed insiders bought or sold shares recently?6 sales
In the 90 days to 10 Nov 2026, Chemed insiders reported 6 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 21 Oct 2025, show no open-market purchase. A further 4 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders
Which funds own Chemed?1 of 45
1 of the 45 funds we track reported a Chemed position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported position was Fisher Asset Management. See Funds
Have members of Congress traded Chemed?3 trades
Yes. 3 trades in Chemed appear in the congressional disclosures we hold; the latest is a purchase by Lisa C. McClain (House, MI) dated 24 Jun 2025, filed 13 Aug 2025. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress
When did Chemed last report earnings?5.45
Chemed last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of 5.45 USD; no next date is announced in SEC filings yet. See Filings
What is Reddit saying about Chemed?0 mentions
Chemed was mentioned 0 times in the last 7 days across the finance subreddits we track, and 23 times over the trailing 30 days. Of the 23 mentions scored for sentiment, 87% read bullish and 0% bearish. That is a social signal, not investment advice. See Reddit
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), most closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- Wikimedia CommonsPortraits via Wikimedia Commons. Lisa C. McClain: Office of Congresswoman Lisa McClain, Public domain; Byron Donalds: United States Congress, Public domain; Daniel S. Goldman: US House, Public domain.
- House disclosuresU.S. House of Representatives financial disclosures
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings